Joe-elie Salem

Alıntı yapanlar

	Hepsi	2020 yılından bugüne
Alıntılar	17020	15659
h-endeksi	57	56
i10-endeksi	154	150

4400

2200

1100

3300

201720182019202020212022202320242025132 273 780 1633 2339 2997 3675 4312 624

Genel erişim

Tümünü görüntüle

89 makale

0 makale

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

Javid MoslehiUniversity of California, San Francisco (UCSF)ucsf.edu üzerinde doğrulanmış e-posta adresine sahip
Christian Funck-BrentanoProfesseur Émérite - Faculté de Santé Sorbonne Universitéaphp.fr üzerinde doğrulanmış e-posta adresine sahip
Douglas B JohnsonProfessor of Medicine, Vanderbilt University Medical Centervumc.org üzerinde doğrulanmış e-posta adresine sahip
Dan RodenProfessor of Medicine, Pharmacology, and Biomedical Informatics, Vanderbilt University Medical Ctrvanderbilt.edu üzerinde doğrulanmış e-posta adresine sahip
Lee S. NguyenGroupe Hospitalier Privé Ambroise Paré - Hartmann; INSERMclinique-a-pare.fr üzerinde doğrulanmış e-posta adresine sahip
Jean-Sébastien HulotUniversité Paris Citéaphp.fr üzerinde doğrulanmış e-posta adresine sahip
Olivier BenvenisteProfesseur de Médecine Interne et Immunologie Clinique, Sorbonne Universitéaphp.fr üzerinde doğrulanmış e-posta adresine sahip
Ali ManouchehriClinical Pharmacology Research Fellow; Vanderbilt University Medical Centervumc.org üzerinde doğrulanmış e-posta adresine sahip
Joachim AlexandrePharmacology, MD, PhD, Caen Universitychu-caen.fr üzerinde doğrulanmış e-posta adresine sahip
kerneis mathieuCardiology, Hôpital de la Pitié-Salpétrière, AP-HPpsl.aphp.fr üzerinde doğrulanmış e-posta adresine sahip
Justin M. BalkoProfessor of Medicine, and Pathology, Microbiology, and Immunology, Vanderbilt Universityvumc.org üzerinde doğrulanmış e-posta adresine sahip
Tao YangVanderbilt Universityvanderbilt.edu üzerinde doğrulanmış e-posta adresine sahip
David KlatzmannSorbonne University & Pitié-Salpêtrière Hospitalsorbonne-universite.fr üzerinde doğrulanmış e-posta adresine sahip
Franck ThunyAix-Marseille University, Department of Cardiology, Nord Hospital, Marseille, Franceuniv-amu.fr üzerinde doğrulanmış e-posta adresine sahip
Lisa BastaracheVanderbilt University Medical Center - Research Associate ProfessorVanderbilt.Edu üzerinde doğrulanmış e-posta adresine sahip
Andrew MammenNational Institutes of Healthnih.gov üzerinde doğrulanmış e-posta adresine sahip
Andrew GlazerVanderbilt University Medical Centervumc.org üzerinde doğrulanmış e-posta adresine sahip
Marc Bonaca MD MPHProfessor of Medicine, University of Colorado School of Medicinecpcmed.org üzerinde doğrulanmış e-posta adresine sahip
francoise hidden-lucetmédecin rythmologue APHPaphp.fr üzerinde doğrulanmış e-posta adresine sahip
Nadia AissaouiCardiologie, HEGP, Université Paris Cité, Franceaphp.fr üzerinde doğrulanmış e-posta adresine sahip

Takip et

Joe-elie Salem

APHP

aphp.fr üzerinde doğrulanmış e-posta adresine sahip - Ana Sayfa

Clinical Pharmacology - Cardio-Oncology


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis DY Wang, JE Salem, JV Cohen, S Chandra, C Menzer, F Ye, S Zhao, ... JAMA oncology 4 (12), 1721-1728, 2018	2347	2018
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology … AR Lyon, T López-Fernández, LS Couch, R Asteggiano, MC Aznar, ... European Heart Journal-Cardiovascular Imaging 23 (10), e333-e465, 2022	2018	2022
Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study JE Salem, A Manouchehri, M Moey, B Lebrun-Vignes, L Bastarache, ... The Lancet Oncology 19 (12), 1579-1589, 2018	1038	2018
Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis JJ Moslehi, JE Salem, JA Sosman, B Lebrun-Vignes, DB Johnson The Lancet 391 (10124), 933, 2018	851	2018
Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised … G Cayla, T Cuisset, J Silvain, F Leclercq, S Manzo-Silberman, ... The Lancet 388 (10055), 2015-2022, 2016	415*	2016
Statin therapy is associated with lower prevalence of gut microbiota dysbiosis S Vieira-Silva, G Falony, E Belda, T Nielsen, J Aron-Wisnewsky, ... Nature 581 (7808), 310-315, 2020	393	2020
Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial M Rosenzwajg, R Lorenzon, P Cacoub, HP Pham, F Pitoiset, K El Soufi, ... Annals of the rheumatic diseases 78 (2), 209-217, 2019	386	2019
Myocarditis in the setting of cancer therapeutics: proposed case definitions for emerging clinical syndromes in cardio-oncology MP Bonaca, BA Olenchock, JE Salem, SD Wiviott, S Ederhy, A Cohen, ... Circulation 140 (1), 80-91, 2019	385	2019
Abatacept for severe immune checkpoint inhibitor–associated myocarditis JE Salem, Y Allenbach, A Vozy, N Brechot, DB Johnson, JJ Moslehi, ... New England Journal of Medicine 380 (24), 2377-2379, 2019	381	2019
Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study DB Johnson, A Manouchehri, AM Haugh, HT Quach, JM Balko, ... Journal for immunotherapy of cancer 7, 1-9, 2019	319	2019
Cardiovascular toxicity related to cancer treatment: a pragmatic approach to the American and European cardio‐oncology guidelines J Alexandre, J Cautela, S Ederhy, GL Damaj, JE Salem, F Barlesi, ... Journal of the American Heart Association 9 (18), e018403, 2020	259	2020
Cardiovascular toxicities associated with ibrutinib JE Salem, A Manouchehri, M Bretagne, B Lebrun-Vignes, JD Groarke, ... Journal of the American College of Cardiology 74 (13), 1667-1678, 2019	250	2019
A genetic mouse model recapitulates immune checkpoint inhibitor–associated myocarditis and supports a mechanism-based therapeutic intervention SC Wei, WC Meijers, ML Axelrod, NAAS Anang, EM Screever, ... Cancer discovery 11 (3), 614-625, 2021	213	2021
Increased jejunal permeability in human obesity is revealed by a lipid challenge and is linked to inflammation and type 2 diabetes L Genser, D Aguanno, HA Soula, L Dong, L Trystram, K Assmann, ... The Journal of pathology 246 (2), 217-230, 2018	193	2018
Ibrutinib-mediated atrial fibrillation attributable to inhibition of C-terminal Src kinase L Xiao, JE Salem, S Clauss, A Hanley, A Bapat, M Hulsmans, Y Iwamoto, ... Circulation 142 (25), 2443-2455, 2020	191	2020
Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology A Molinaro, P Bel Lassen, M Henricsson, H Wu, S Adriouch, E Belda, ... Nature communications 11 (1), 5881, 2020	189	2020
Immune checkpoint inhibitor–associated myositis: expanding the spectrum of cardiac complications of the immunotherapy revolution C Anquetil, JE Salem, B Lebrun-Vignes, DB Johnson, AL Mammen, ... Circulation 138 (7), 743-745, 2018	189	2018
Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB1 genetic polymorphisms and interaction with clarithromycin I Gouin‐Thibault, X Delavenne, A Blanchard, V Siguret, JE Salem, ... Journal of Thrombosis and Haemostasis 15 (2), 273-283, 2017	188	2017
Combinatorial, additive and dose-dependent drug–microbiome associations SK Forslund, R Chakaroun, M Zimmermann-Kogadeeva, L Markó, ... Nature 600 (7889), 500-505, 2021	178	2021
A case report of clonal EBV-like memory CD4⁺ T cell activation in fatal checkpoint inhibitor-induced encephalitis DB Johnson, WJ McDonnell, PI Gonzalez-Ericsson, RN Al-Rohil, ... Nature medicine 25 (8), 1243-1250, 2019	172	2019

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar